DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of “Hold” from Brokerages

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has been given an average rating of “Hold” by the twelve analysts that are presently covering the firm, MarketBeat.com reports. Eight investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $27.27.

XRAY has been the topic of several research analyst reports. Mizuho began coverage on shares of DENTSPLY SIRONA in a report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price target on the stock. Barrington Research cut their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, November 8th. Morgan Stanley decreased their price objective on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, UBS Group decreased their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a report on Tuesday, December 3rd.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $18.06 on Friday. The business’s fifty day moving average is $18.96 and its 200 day moving average is $22.98. The firm has a market cap of $3.59 billion, a price-to-earnings ratio of -8.72, a PEG ratio of 1.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. DENTSPLY SIRONA has a 52-week low of $17.21 and a 52-week high of $36.63.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company’s revenue for the quarter was up .4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.49 earnings per share. Research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, January 10th. Shareholders of record on Friday, December 27th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.54%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of XRAY. First Eagle Investment Management LLC boosted its holdings in DENTSPLY SIRONA by 33.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after acquiring an additional 3,283,965 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after purchasing an additional 1,308,411 shares during the period. JPMorgan Chase & Co. grew its holdings in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock worth $49,990,000 after purchasing an additional 1,244,326 shares during the last quarter. Invenomic Capital Management LP purchased a new position in shares of DENTSPLY SIRONA in the third quarter worth $23,724,000. Finally, National Bank of Canada FI boosted its position in DENTSPLY SIRONA by 85.8% during the 3rd quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier’s stock valued at $44,059,000 after buying an additional 751,800 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.